|
|||||
|
|
Current management of patients with gastrointestinal stromal tumor receiving the multitargeted tyrosine kinase inhibitor sunitinib |
|
| Authors: | Amy Potter Pilotte |
| Affiliation: | 1. Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, MA, USA;2. Rhode Island Hospital Comprehensive Cancer Center, Providence, RI, USA |
| Abstract: | |
| Keywords: | GIST Sarcoma Side-effect management Sunitinib Tyrosine kinase inhibitors |